Athos
About Athos
Athos is an investment firm focused on entrepreneurially and value-based investing, with a specialization in Pharma and Life Science. It targets technology-driven companies and real estate, operating primarily in the European market as indicated by its German web presence. The firm emphasizes value-based investing and partnerships with companies in the pharmaceutical and life sciences sectors. Headquartered or active in a German-speaking region, Athos presents itself as a niche investor within biotech, pharma, and related healthcare fields.
Recent News
Antheia Raises $24M in Second Close of Series C Financing
Doctolib's 40% Secondary Market Devaluation: Primary Drivers of European HealthTech Market Recalibration
Kanvas Biosciences Receives New Funding to Develop First-In-Category Microbiome Therapeutic for Improving Maternal, Newborn and Child Health
Funding Roundup: Kanvas Biosciences, LTZ Therapeutics Draw Investor Interest for Next-Generation Cancer Immunotherapies